Literature DB >> 16051523

In vitro effect of statins on cytokine production and mitogen response of human peripheral blood mononuclear cells.

Hanna Bessler1, Hertzel Salman, Michael Bergman, Rachel Straussberg, Meir Djaldetti.   

Abstract

The in vitro effect of the hydrophilic statin - pravastatin - and three hydrophobic statins - atorvastatin, lovastatin and simvastatin - on the production of IL-1beta, IL-1ra, IL-2, IL-6 and IFN-gamma by human peripheral blood mononuclear cells (PBMC) and their response to mitogens was examined. Lovastatin and simvastatin increased the production of IL-1beta in a dose dependent manner and reduced secretion of IL-1ra at high concentration. These two statins exerted a dose dependent inhibitory effect on IL-2 production and reduced the secretion of IFNgamma at high dose. Atorvastatin did not affect IL-1beta, but suppressed IL-1ra, IL-2 and IFNgamma production. Atorvastatin, lovastatin and simvastatin caused a dose dependent inhibition of mitogen-induced proliferation of PBMC. IL-6 production was not affected by any one of the statins. While pravastatin caused a slight reduction in the proliferative response of PBMC to PHA, it did not affect either their response to Con A and PWM, or the secretion of cytokines tested.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16051523     DOI: 10.1016/j.clim.2005.06.014

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  15 in total

1.  Impact of Statins on Influenza Vaccine Effectiveness Against Medically Attended Acute Respiratory Illness.

Authors:  Saad B Omer; Varun K Phadke; Robert A Bednarczyk; Allison T Chamberlain; Jennifer L Brosseau; Walter A Orenstein
Journal:  J Infect Dis       Date:  2015-10-28       Impact factor: 5.226

2.  Biomarker assessment of the immunomodulator effect of atorvastatin in stable renal transplant recipients and hypercholesterolemic patients.

Authors:  David Guillén; Federico Cofán; Emilio Ros; Olga Millán; Montse Cofán; Mercè Brunet
Journal:  Mol Diagn Ther       Date:  2010-12-01       Impact factor: 4.074

3.  Usefulness of targeting lymphocyte Kv1.3-channels in the treatment of respiratory diseases.

Authors:  Itsuro Kazama; Tsutomu Tamada; Masahiro Tachi
Journal:  Inflamm Res       Date:  2015-07-24       Impact factor: 4.575

4.  Effect of simvastatin on mitochondrial enzyme activities, ghrelin, hypoxia-inducible factor 1α in hepatic tissue during early phase of sepsis.

Authors:  Hatice Yorulmaz; Elif Ozkok; Mine Erguven; Gulten Ates; Irfan Aydın; Sule Tamer
Journal:  Int J Clin Exp Med       Date:  2015-03-15

5.  On the combined effect of statins and lycopene on cytokine production by human peripheral blood cells.

Authors:  Michael Bergman; Meir Djaldetti; Hertzel Salman; Hanna Bessler
Journal:  Heart Vessels       Date:  2010-07-31       Impact factor: 2.037

6.  Inhibitory effect of statins on inflammatory cytokine production from human bronchial epithelial cells.

Authors:  A Iwata; R Shirai; H Ishii; H Kushima; S Otani; K Hashinaga; K Umeki; K Kishi; I Tokimatsu; K Hiramatsu; J Kadota
Journal:  Clin Exp Immunol       Date:  2012-05       Impact factor: 4.330

7.  Early statin use is associated with increased risk of infection after stroke.

Authors:  Kyra Becker; Pat Tanzi; Angela Kalil; Dean Shibata; Kevin Cain
Journal:  J Stroke Cerebrovasc Dis       Date:  2011-07-22       Impact factor: 2.136

8.  Anthocyanins enriched purple tea exhibits antioxidant, immunostimulatory and anticancer activities.

Authors:  Robin Joshi; Ajay Rana; Vinay Kumar; Dharmesh Kumar; Yogendra S Padwad; Sudesh Kumar Yadav; Ashu Gulati
Journal:  J Food Sci Technol       Date:  2017-04-18       Impact factor: 2.701

9.  Repression of BK virus infection of human renal proximal tubular epithelial cells by pravastatin.

Authors:  Takahito Moriyama; Andrey Sorokin
Journal:  Transplantation       Date:  2008-05-15       Impact factor: 4.939

10.  Influenza morbidity and mortality in elderly patients receiving statins: a cohort study.

Authors:  Jeffrey C Kwong; Ping Li; Donald A Redelmeier
Journal:  PLoS One       Date:  2009-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.